This was unexpected since previous studies report that MEK/ERK signaling regulates c-Jun expression in BRAFV600E melanomas and, thus, that RAF and MEK inhibitors should down-regulate c-Jun (Lopez-Bergami et al, 2007). This evidence concerns the gene MAP2K7 and melanoma.